An increasing number of studies have described that KDM2A exerts an oncogenic role in a wide range of tumor types, including breast cancer, gastric cancer and lung cancer, and can enhance the growth and motility of cancer cells to promote tumor progression [8–12]. Here, KDM2A is linked to gastric cancer.